On January 15, 2021, Ha Tay Pharmaceutical JSC (HNX:DHT) closed the transaction. All the shares issued in the transaction were subscribed by ASKA Pharmaceutical Co., Ltd. (TSE:4514). The investor will now hold 24.9% stake in the company.
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
34,000 VND | -5.03% | +17.24% | +47.83% |
1st Jan change | Capi. | |
---|---|---|
+47.83% | 116M | |
+32.91% | 709B | |
+30.77% | 595B | |
-1.78% | 367B | |
+20.21% | 334B | |
+5.95% | 289B | |
+14.77% | 239B | |
+9.13% | 211B | |
-3.97% | 203B | |
+8.99% | 171B |
- Stock Market
- Equities
- DHT Stock
- News Ha Tay Pharmaceutical
- Ha Tay Pharmaceutical JSC announced that it has received VND 369.70241 billion in funding from ASKA Pharmaceutical Co., Ltd.